S4332Referred to Committee

A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

Share:
Introduced
2
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-04-16
Introduced
1
Cosponsors
S
Type

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-04-16

Read the full bill text